Shengtao Yang Selected Research

Inflammation (Inflammations)

1/2024	Distribution profiles of phenolic compounds in a cultivar of wampee (Clausena lansium (Lour.) Skeels) fruits and in vitro anti-inflammatory activity.
1/2023	The anti-inflammatory activity of GABA-enriched Moringa oleifera leaves produced by fermentation with Lactobacillus plantarum LK-1.
10/2022	Inhibition of glutamate-carboxypeptidase-II in dorsolateral prefrontal cortex: potential therapeutic target for neuroinflammatory cognitive disorders.
7/2022	Pentapeptide AYP from Isochrysis Zhanjiangensis Exhibits Antiangiogenic Activity in HT1080 Cells and HUVECs by Suppressing Migration and Invasion In Vitro.
1/2022	A novel glyceroglycolipid from brown algae Ishige okamurae improve photoaging and counteract inflammation in UVB-induced HaCaT cells.
3/2021	The Inhibition Effect of the Seaweed Polyphenol, 7-Phloro-Eckol from Ecklonia Cava on Alcohol-Induced Oxidative Stress in HepG2/CYP2E1 Cells.
1/2021	Structural Characterization of Sulfated Polysaccharide Isolated From Red Algae (Gelidium crinale) and Antioxidant and Anti-Inflammatory Effects in Macrophage Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shengtao Yang Research Topics

Disease

7	Inflammation (Inflammations) 01/2024 - 01/2021
6	Neoplasms (Cancer) 07/2022 - 05/2017
2	Infections 10/2022 - 01/2021
2	COVID-19 10/2022 - 01/2021
1	Cognitive Dysfunction 10/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Second Primary Neoplasms (Neoplasms, Second) 01/2022
1	Hypoxia (Hypoxemia) 11/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2021
1	Schizophrenia (Dementia Praecox) 01/2021
1	Mental Fatigue 01/2021
1	Delirium 01/2021
1	Sepsis (Septicemia) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Neuroinflammatory Diseases 01/2021

Drug/Important Bio-Agent (IBA)

2	LipopolysaccharidesIBA 01/2024 - 01/2021
2	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 11/2021
2	Proteins (Proteins, Gene)FDA Link 03/2021 - 01/2018
1	gamma-Aminobutyric Acid (GABA)IBA 01/2023
1	metabotropic glutamate receptor 3 (mGluR3)IBA 10/2022
1	Glutamate Carboxypeptidase II (N-Acetylaspartylglutamate Peptidase)IBA 10/2022
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 10/2022
1	prolylglutamic acidIBA 07/2022
1	alanyl-tyrosyl-alanineIBA 07/2022
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 11/2021
1	Angiogenesis InhibitorsIBA 11/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2021
1	Glutathione (Reduced Glutathione)IBA 03/2021
1	Caspase 9IBA 03/2021
1	Caspase 3 (Caspase-3)IBA 03/2021
1	Superoxide DismutaseIBA 03/2021
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 03/2021
1	Kynurenic Acid (Kynurenate)IBA 01/2021
1	KynurenineIBA 01/2021
1	polyoxometalateIBA 07/2018
1	Amino Acids FDA Link 01/2018
1	InterferonsIBA 01/2018
1	PolymersIBA 01/2018
1	MicellesIBA 05/2017

Therapy/Procedure

1	Colectomy 01/2022
1	Adjuvant Chemotherapy 01/2022
1	Photothermal Therapy 07/2018